Interactive Survivorship Program for the Improvement of Healthcare Resources in Adolescent and Young Adult Cancer Survivors, INSPIRE-AYA Study
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Malignant Solid Neoplasm
- Clinical Stage IIA Cutaneous Melanoma AJCC v8
- Clinical Stage I Cutaneous Melanoma AJCC v8
- Clinical Stage IA Cutaneous Melanoma AJCC v8
- Clinical Stage IB Cutaneous Melanoma AJCC v8
- Pathologic Stage II Cutaneous Melanoma AJCC v8
- Stage IIIC Colorectal Cancer AJCC v8
- Stage IIB Colorectal Cancer AJCC v8
- Stage III Colorectal Cancer AJCC v8
- Pathologic Stage IA Cutaneous Melanoma AJCC v8
- Stage IIIB Colorectal Cancer AJCC v8
- Pathologic Stage IIC Cutaneous Melanoma AJCC v8
- Stage I Colorectal Cancer AJCC v8
- Clinical Stage II Cutaneous Melanoma AJCC v8
- Stage IIC Colorectal Cancer AJCC v8
- Pathologic Stage III Cutaneous Melanoma AJCC v8
- Sarcoma
- Stage IIIA Colorectal Cancer AJCC v8
- Pathologic Stage IIA Cutaneous Melanoma AJCC v8
- Pathologic Stage IIB Cutaneous Melanoma AJCC v8
- Clinical Stage IIB Cutaneous Melanoma AJCC v8
- Stage IIA Colorectal Cancer AJCC v8
- Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
- Clinical Stage IIC Cutaneous Melanoma AJCC v8
- Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
- Lymphoma
- Clinical Stage III Cutaneous Melanoma AJCC v8
- Hematopoietic and Lymphoid Cell Neoplasm
- Invasive Malignant Neoplasm
- Leukemia
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
- Pathologic Stage I Cutaneous Melanoma AJCC v8
- Stage II Colorectal Cancer AJCC v8
- Pathologic Stage IB Cutaneous Melanoma AJCC v8
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
OUTLINE: Patients who have one or more elevated distress or low cardiometabolic or cancer health care adherence are randomized to Arm I or II. Patients who do not have elevated distress or low cardiometabolic or cancer health care adherence are assigned to Group 0. ARM I (INTERVENTION): Patients rec...
OUTLINE: Patients who have one or more elevated distress or low cardiometabolic or cancer health care adherence are randomized to Arm I or II. Patients who do not have elevated distress or low cardiometabolic or cancer health care adherence are assigned to Group 0. ARM I (INTERVENTION): Patients receive a personalized smart cell phone (SCP) and use the Interactive Survivorship Program to Improve Healthcare Resources (INSPIRE) mobile application. Patients may receive telehealth stepped care after 1 month. ARM II (CONTROL): Patients receive access to a study-specific control website that has annotated links to existing resources for adolescent and young adult (AYA) survivors. After 12 months, patients receive a personalized SCP and have access to the digital INSPIRE intervention program without telehealth calls. GROUP 0: Patients have access to the digital INSPIRE program and receive printed SCP materials without telehealth.
Tracking Information
- NCT #
- NCT04593277
- Collaborators
- National Cancer Institute (NCI)
- Investigators
- Principal Investigator: Karen L. Syrjala Fred Hutch/University of Washington Cancer Consortium
Get Well Soon